Cohen Yuval bought CRBP
October 24, 2025 · Form 4 insider transaction
Cohen Yuval bought 18,660 shares of Corbus Pharmaceuticals Holdings, Inc. at $4.26 per share, a transaction worth $79.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,660
Price
$4.26
Total value
$79.5K
InsiderCohen Yuval
RoleOfficer, Director
SecurityCommon Stock, par value $0.0001 per share
Transaction codeM: Option exercise
Transaction dateOctober 24, 2025
Filing dateOctober 27, 2025
Shares owned after156,847
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported.